본문으로 건너뛰기
← 뒤로

Anti-AMPAR limbic encephalitis as the initial presentation of metastatic small cell cancer.

BMJ case reports 2026 Vol.19(2)

Kakarala CL, Mehta V, Lisek N, Hao Z

📝 환자 설명용 한 줄

A small proportion of small cell lung cancer (SCLC) presents as paraneoplastic limbic encephalitis (PLE).

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Kakarala CL, Mehta V, et al. (2026). Anti-AMPAR limbic encephalitis as the initial presentation of metastatic small cell cancer.. BMJ case reports, 19(2). https://doi.org/10.1136/bcr-2025-268896
MLA Kakarala CL, et al.. "Anti-AMPAR limbic encephalitis as the initial presentation of metastatic small cell cancer.." BMJ case reports, vol. 19, no. 2, 2026.
PMID 41629117

Abstract

A small proportion of small cell lung cancer (SCLC) presents as paraneoplastic limbic encephalitis (PLE). The most implicated antibody is anti-Hu, but others such as anti-ampiphysin, anti-CRMP5 and anti-SOX1 have been frequently detected. Autoimmune encephalitis mediated by antibodies against α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) is a rare but important neurological complication of SCLC. The incidence of SCLC presenting with anti-AMPAR antibody PLE is extremely low. Our case illustrates a rare presentation of SCLC with an intention to highlight the importance of evaluating for malignancy and associated paraneoplastic syndromes in patients with unexplained encephalopathy.

MeSH Terms

Humans; Limbic Encephalitis; Small Cell Lung Carcinoma; Lung Neoplasms; Male; Autoantibodies; Receptors, AMPA; Middle Aged; Fatal Outcome